Izalontamab Brengitecan Advances Milestones, Bedrock Feeds Southern Ocean Iron, HPV Vaccine Protects for 18 Years, Mosquito Blood Preference Traced, and more...

(0:10): Izalontamab Brengitecan Hits Key Milestones in Advanced Breast Cancer Trial, Investors Remain Cautious(2:50): Rutgers Study Reveals Bedrock, Not Glaciers, as Key Iron Source to Southern Ocean(5:20): New Study Confirms Long-Term HPV Vaccine Protection Against Cervical Cancer Over 18 Years(7:42): Mosquito Evolution: Human Blood Preference Originated 1.8 Million Years Ago with Homo Erectus(9:48): Eli Lilly's New Pill Shows Promise in Revolutionizing Type 2 Diabetes and Weight ManagementTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news.